Preparation of sodium deoxycholate (DOC) conjugated heparin derivatives for inhibition of angiogenesis and cancer cell growth

Department of Otolaryngology, Head and Neck Surgery, The Catholic University of Korea, College of Medicine Uijeongbu, St. Mary's Hospital, Kyunggi-Do 480-717, Korea.
Bioconjugate Chemistry (Impact Factor: 4.82). 08/2008; 19(7):1346-51. DOI: 10.1021/bc800173m
Source: PubMed

ABSTRACT We describe new DOC (sodium deoxycholate)-heparin nanoparticles for in vivo tumor targeting and inhibition of angiogenesis based on chemical conjugation and the enhanced permeability and retention (EPR) effect. Heparin has been used as a potent anticoagulant agent for 70 years, and has recently been found to inhibit the activity of growth factors which stimulate the smooth muscle cells around tumor. From the results, DOC and heparin were conjugated by bonding carboxyl groups of heparin with amine groups of aminated sodium deoxycholate. Larger antitumor effects of the DOC-heparin VI (8.5 mol of DOC coupled with 1.0 mol heparin) were achieved in animal studies, compared to heparin alone. We confirmed that the conjugated heparin retained its ability to inhibit binding with angiogenic factor, showing a significant decrease in endothelial tubular formation. These results provide new insights into the nontoxic anticancer drug carrier as well as the design of multifunctional bioconjugates for targeted drug delivery.

1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In this study, three types of hybrid nanotubes (NTs), ie, oxidized multiwalled carbon NTs (COOH MWCNTs), heparin (Hep)-conjugated MWCNTs (Hep MWCNTs), and diblock copolymer polyglycolic acid (PGA)-co-heparin conjugated to MWCNTs (PGA MWCNTs), were synthesized with improved biocompatibility and drug-loading capacity. Hydrophilic Hep substituents on MWCNTs improved biocompatibility and acted as nucleus-sensitive segments on the CNT carrier, whereas the addition of PGA enhanced drug-loading capacity. In the PGA MWCNT system, the amphiphilic copolymer (PGA-Hep) formed micelles on the side walls of CNTs, as confirmed by electron microscopy. The PGA system encapsulated the hydrophobic drug with high efficiency compared to the COOH MWCNT and Hep MWCNT systems. This is because the drug was loaded onto the PGA MWCNTs through hydrophobic forces and onto the CNTs by π-π stacking interactions. Additionally, most of the current drug-carrier designs that target cancer cells release the drug in the lysosome or cytoplasm. However, nuclear-targeted drug release is expected to kill cancer cells more directly and efficiently. In our study, PGA MWCNT carriers effectively delivered the active anticancer drug doxorubicin into targeted nuclei. This study may provide an effective strategy for the development of carbon-based drug carriers for nuclear-targeted drug delivery.
    International Journal of Nanomedicine 11/2013; 8:4427-40. DOI:10.2147/IJN.S53636 · 4.20 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To achieve a targeted drug delivery system for chemotherapy, we synthesized a ligand-mediated nanoparticulate drugcarrier composed of folate-conjugated heparin-based copolymers. The use of a heparin-based drug delivery system is of special interest due to the attractive anticancer properties of heparin. Heparin–poly(β-benzyl-L-aspartate) (HP) and folate–poly(ethylene glycol)-conjugated HP (FPHP) amphiphilic copolymers were synthesized for delivery of doxorubicin (DOX). DOX was effectively incorporated into HP and FPHPnanoparticles at a high loading content and efficiency by a simple dialysis method. The DOX-loaded HP and FPHPnanoparticles had average diameters of 86–210 nm, depending on the drug loading content and the compositions of copolymers. Both DOX-loaded HP and FPHPnanoparticles had a sustained drug release pattern, and DOX-release from nanoparticles at pH 5.0 was much faster than that at pH 7.4. This pH-dependent DOX release property may ensure intracellulardrug release due to decreases in pH values inside the endosomes and lysosomes of tumor cells. Furthermore, the DOX-loaded FPHPnanoparticles exhibited a greater extent of intracellular uptake against folate-receptor positive KB cells than DOX-loaded HPnanoparticles, indicating that the FPHPnanoparticles may serve as an effective active targeting carrier. The DOX-loaded FPHPnanoparticles also showed more potent cytotoxic effect on KB cells than on folate-receptor negative A549cells. These results suggested that the FPHPnanoparticle is a promising candidate for targeted delivery of anticancer drugs to folate-receptor positive cells.
    Journal of Materials Chemistry 09/2011; 21(39):15288-15297. DOI:10.1039/C1JM11944C · 6.63 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In the last decade, gold and silver nanomaterials have received considerable attention due to their attractive electronic and chemical properties and their potential applications in the development of new technologies. Recent advances in the study of various gold and silver nanomaterials have led to their utilization in a number of very important applications including biosensing, diagnostic imaging, and cancer diagnosis and therapy. This review surveys the various synthetic methods of gold and silver nanomaterials. Recent experimental studies focusing on the use of gold and silver nanomaterials in catalysis, food industry, and environmental conservation are also reviewed. This review also highlights the advantages of gold and silver nanomaterials in the development of fluorescence biosensors, glucose biosensors, nucleic acids-based biosensors, and protein-based biosensors. Moreover, the potent in vitro and in vivo anti-microbial and cyto-genotoxic effects of various gold and silver nanomaterials are underlined. Finally, recent advances in the employment of gold and silver nanomaterials as effective drug delivery vehicles and promising cancer therapeutic agents are summarized. Despite their use in remediating numerous medical and health-related conditions, the efficacy and safety of many gold and silver nanomaterials is still under some scrutiny. Needless to say, researchers are facing many challenges and obstacles in their ample attempts to synthesize nanomaterials that are relatively easy to design, inexpensive to fabricate, and effective in treating various diseases, but at the same time display a very low, if any, toxicity to the body. Future investigations should aim at overcoming such challenges in an attempt to design nanomaterials that will prove to be useful in diagnosing and treating life-threatening diseases while ensuring a high degree of efficacy and safety.
    Journal of Nanoscience and Nanotechnology 07/2014; 14(7):4757-80. DOI:10.1166/jnn.2014.9526 · 1.34 Impact Factor


Available from